
Sign up to save your podcasts
Or


In this episode of Prescribed Listening from The University of Toledo Medical Center, Dr. Mohamed Omballi, whose focus is in Interventional Pulmonary Medicine Disease. Today, he discusses the zephyr valve implant, which was approved by the FDA in 2018 to treat severe emphysema. The implant is a less invasive treatment that expands the options available to patients and allows for an increase in quality of life.
By The University of Toledo5
1515 ratings
In this episode of Prescribed Listening from The University of Toledo Medical Center, Dr. Mohamed Omballi, whose focus is in Interventional Pulmonary Medicine Disease. Today, he discusses the zephyr valve implant, which was approved by the FDA in 2018 to treat severe emphysema. The implant is a less invasive treatment that expands the options available to patients and allows for an increase in quality of life.